彪马 PBYI
$8.25 −$1.52 (-15.56%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.96 -3.50%
开盘$8.27
昨收$9.77
当日区间$7.59 – $8.65
成交量1.28M
市值$425.87M
市盈率（TTM）17.9
股息率–
PBYI 相关新闻
匹配 Puma Biotechnology 或代码 PBYI 的头条新闻，按最新排序。
- Earnings Call Summary | Puma Biotechnology(PBYI.US) Q4 2025 Earnings Conference
- Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... 正面
- Puma Biotechnology (PBYI.US) will release its earnings report after the market close on November 5.
- TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $4
- H.C. Wainwright Maintains Puma Biotechnology(PBYI.US) With Buy Rating, Maintains Target Price $7
- TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $5
- Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ... 正面
- TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Raises Target Price to $5 正面
- Barclays Maintains Puma Biotechnology(PBYI.US) With Sell Rating, Maintains Target Price $2
- IRWD Vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
- HC Wainwright & Co. : The Puma Biotechnology (PBYI.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.
- H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI)
- H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI)
- H.C. Wainwright Sticks to Its Buy Rating for Puma Biotechnology (PBYI)
暂无评论——快来第一个聊聊 PBYI。